title: Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital.
abstract: We evaluated three commercial colistin susceptibility testing methods using 213 bloodstream Acinetobacter isolates identified by gene sequencing. Compared to the agar dilution reference method, excellent categorical agreements (both 99.1%) were observed using Vitek 2 and Etest, compared to 87.3% (95.7% for Acinetobacter baumannii and 80.7% for non-baumannii Acinetobacter isolates) using MicroScan.
authors.affiliation: Department of Laboratory Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
authors.forename: Seung Yeob
authors.initials: SY
authors.lastname: Lee
authors.forename: Jong Hee
authors.initials: JH
authors.lastname: Shin
authors.forename: Kyungwon
authors.initials: K
authors.lastname: Lee
authors.forename: Min Young
authors.initials: MY
authors.lastname: Joo
authors.forename: Kyung Hwa
authors.initials: KH
authors.lastname: Park
authors.forename: Myung Geun
authors.initials: MG
authors.lastname: Shin
authors.forename: Soon Pal
authors.initials: SP
authors.lastname: Suh
authors.forename: Dong Wook
authors.initials: DW
authors.lastname: Ryang
authors.forename: Soo Hyun
authors.initials: SH
authors.lastname: Kim
mesh_terms: D000151:Acinetobacter Infections / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology*; D003091:Colistin / Q000494:pharmacology*; D006785:Hospitals, University; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D056910:Republic of Korea
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin
references.citation: J Clin Microbiol. 2004 Sep;42(9):3925-31
references.pmid: 15364970
references.citation: J Antimicrob Chemother. 2004 Apr;53(4):604-8
references.pmid: 14973153
references.citation: J Clin Microbiol. 2010 Apr;48(4):1445-9
references.pmid: 20181894
references.citation: J Antimicrob Chemother. 2010 Feb;65(2):367-9
references.pmid: 20008049
references.citation: Clin Microbiol Infect. 2007 May;13(5):541-4
references.pmid: 17371537
references.citation: J Clin Microbiol. 2006 Mar;44(3):827-32
references.pmid: 16517861
references.citation: J Antimicrob Chemother. 2012 Jul;67(7):1607-15
references.pmid: 22441575
references.citation: Antimicrob Agents Chemother. 2007 Oct;51(10):3726-30
references.pmid: 17646414
references.citation: J Antimicrob Chemother. 2011 Jan;66(1):66-72
references.pmid: 21051374
references.citation: J Antimicrob Chemother. 2010 Jul;65(7):1416-23
references.pmid: 20430789
references.citation: J Clin Microbiol. 2005 Feb;43(2):903-5
references.pmid: 15695701
references.citation: Future Microbiol. 2011 Apr;6(4):407-22
references.pmid: 21526942